康緣藥業(600557.SH):目前公司營業收入主要來自醫院臨牀端銷售收入
格隆匯12月18日丨康緣藥業(600557.SH)在投資者互動平台表示,目前公司營業收入主要來自醫院臨牀端銷售收入。學術推廣是公司醫藥銷售的主要特色,公司堅持自建銷售隊伍,成立臨牀自營業態、OTC零售業態、分銷業態包括電商和第三終端等銷售團隊,依靠專業學術推廣隊伍,通過專業醫療領域的學術帶頭人和各種層級、各種形式的學術推廣活動,把產品臨牀應用研究成果傳遞給各級醫療機構目標醫生與從業人員,從而提高公司醫藥產品的知名度和醫生的認可度。 院外市場也是公司產品的重要銷售渠道,包括線上平台及線下藥店。公司正加大力度積極進行銷售佈局,以百強和頭部連鎖為核心、並擴大全國中小連鎖和單體藥店以及診所等終端的覆蓋。線上渠道頭部B2C、B2B、O2O電商平台,也同步銷售。您可以在線下實體藥店、京東大藥房、阿里大藥房、美團等頭部電商藥店,康緣旗艦店購買金振口服液、杏貝止咳顆粒等重點品種。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.